Where Global Innovation
and Capital Meet
Sectors Consumer University Energy Financial Healthcare Industrial IT Media Services Telecoms Transport The Art of CVC Startups

Page 200

Case study: Facebook

Facebook advertises its returns to corporations,

Jan 31, 2012

FXall hoping for special effect from IPO

FXall, the electronic trading platform formerly known as FX Alliance, which is backed by a range of financial services firms, will offer its shares at between $13.50 and $15.50 when it floats.

Jan 31, 2012

Verastem gets $55m in IPO treatment

The oncological drug developer backed by the firm of SR One's founder outstrips expectations as it raises $55m from its initial public offering, seeing its price rise after the first day of trading.

Jan 30, 2012

Ceres set to feed on IPO cash

The agricultural and biomass technology firm is looking to raise $100m when it floats, with shareholders including Monsanto set for a return on their investment.

Jan 27, 2012

ChemoCentryx sets range for IPO

GlaxoSmithKline-backed ChemoCentryx is looking to raise up to $64m when it floats, hot on the heels of fellow biopharmaceutical company Verastem.

Jan 26, 2012

Verastem sowing seeds of $46m IPO

The biotechnology researcher, backed by a GlaxoSmithKline-linked venture capital firm, has set the range for its shares for its initial public offering at between $9 and $11.

Jan 17, 2012

Intel-backed AVG preps $125m IPO

With 48 million shares issued, worth an assumed $14.85 each, the market capitalization of AVG would be $712.8m.

Jan 14, 2012

InfoBlox networks way to IPO

The Duchossis-backed computer networking firm is looking to raise up to $125m when it floats.

Jan 10, 2012

Renewable Energy eyes $100m IPO

Corporate-backed biodiesel producer and supplier the Renewable Energy Group sets the range of its IPO, and looks to raise as much as $100m.

Jan 6, 2012

© 2024 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here